Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc > OH, It sound really awful ; - )

<< Previous

Bullboard Posts

Next >>

Comment by SouthernTierTomon Jan 18, 2021 11:17am

161 Views

Post# 32319757

RE:RE:OH, It sound really awful ; - )

Hey Pennis,

Could you share with the class why you signed up 5 years before your first post?

I ask, because known bullbored escorts or "Beech Boys" have been known to have "flunkies" create endless Stockhouse ID's to be used "at a later date"

This news from CPH is really rather weak, even as "BAD NEWS" is rated...

I expect the bullboard to cover this ALL day, like CNN covers what they call, "A terrible story" that boosts their ratings and essentially makes their program ; - )

Hey Pennis...you have a real stink on you ; - )

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec